Waiting Time Intervals for Non-small Cell Lung Cancer Diagnosis and Treatment in Alberta: Quantification of Intervals and Identification of Risk Factors Associated with Delays
Authors:
- 26 June 2016
- journal article
- Published by Elsevier in Clinical Oncology
- Vol. 28 (12) , 750-759
Abstract
No abstract availableKeywords
Funding Information
- Alberta Cancer Foundation (26128)
This publication has 16 references indexed in Scilit:
- Nationwide Quality Improvement in Lung Cancer Care: The Role of the Danish Lung Cancer Group and RegistryJournal of Thoracic Oncology, 2013
- The Andersen Model of Total Patient Delay: A Systematic Review of Its Application in Cancer DiagnosisJournal of Health Services Research & Policy, 2012
- The Aarhus statement: improving design and reporting of studies on early cancer diagnosisBritish Journal of Cancer, 2012
- Using Nurse Navigation to Improve Timeliness of Lung Cancer Care at a Veterans HospitalClinical Journal of Oncology Nursing, 2012
- Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995–2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry dataThe Lancet, 2011
- Redesign of thoracic surgical services within a cancer network-using an oncology focus to inform changeEuropean Journal of Oncology Nursing, 2005
- New ICD-10 version of the Charlson comorbidity index predicted in-hospital mortalityJournal of Clinical Epidemiology, 2004
- Practice OrganizationChest, 2003
- Lung Cancer Treatment Waiting Times and Tumour GrowthClinical Oncology, 2000
- A new method of classifying prognostic comorbidity in longitudinal studies: Development and validationJournal of Chronic Diseases, 1987